Viewpoints

On Strike!

May 02, 2023

Strike action is impacting numerous sectors across Europe, including the bio/pharma industry.

Legislative Hold-Up

April 02, 2023

A further setback to the publication of the pharmaceutical legislative changes in Europe may mean time is running out for appropriate review before 2024 parliamentary elections.

Outsourcing Still Vital

March 02, 2023

The bio/pharma outsourcing industry continues to be integral in the development and manufacture of medicines.

Feeling the Pinch

March 02, 2023

Soaring energy costs are compounding the challenges currently being faced by the European bio/pharma industry.

Improving Gender Diversity

February 02, 2023

Although some headway is being made into more gender-diverse executive levels in pharma, much more work is still needed.

Getting Personal for Blockbusters in 2023

January 02, 2023

The latest report from Clarivate has been published, highlighting 15 potential blockbusters to watch out for in 2023, the majority of which are personalized medicines.

The Next Blockbuster

December 02, 2022

Anti-obesity drugs have the potential to be the next blockbusters, according to market analysis.

Trial Decline

November 02, 2022

Industry and the government must work closely to ensure the UK remains a competitor in the clinical research field.

A Royal Tribute

October 02, 2022

Pharmaceutical Technology Europe pays tribute to the role Her Majesty Queen Elizabeth II had in promoting innovation within life sciences.

Winter is Coming!

September 02, 2022

As winter approaches, the next generation of COVID-19 vaccines are being prepared and scheduled, ready for distribution across Europe and the world.